The Dodgers aren’t done making moves this offseason, and another big one could be on the way. ESPN’s Alden Gonzalez reports L.A. would “not be opposed” to trading Tyler Glasnow. Tyler Glasnow's name ...
The overall goal of this hackathon is to provide hands-on training for the Early Stage Researchers (ESRs) of the REMARO network (but not limited to) on how to architect, program, simulate and ...
Abstract: In this letter we propose a data-driven distributionally robust Model Predictive Control framework for constrained stochastic systems with unbounded additive disturbances. Recursive ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback